Secukinumab provides sustained improvements in clinical and imaging outcomes in patients with psoriatic arthritis and axial manifestations: results from the MAXIMISE trial

Secukinumab provides sustained improvements in clinical and imaging outcomes in patients with psoriatic arthritis and axial manifestations: results from the MAXIMISE trial

Bibliographic Details
Main Authors: Baraliakos, X, Gossec, L, Pournara, E, Jeka, S, Blanco, R, D'Angelo, S, Schett, G, Schulz, B, Rissler, M, Whyms, D, Perella, C, Coates, LC
Format: Conference item
Language:English
Published: Oxford University Press 2021

Similar Items